术后辅助化疗和胆道癌彻底切除后的化疗免疫疗法:一项回顾性研究

Yuhuai Peng1,2, Guoyi Xia3, Yufeng Li2

  • 1Central Laboratory, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University, Changsha, P. R. China.

The oncologist
|June 2, 2025
PubMed
概括

辅助化疗免疫疗法显著改善了切除后胆道癌 (BTC) 的整体存活率. 这种治疗是安全的,并为改善BTC患者的治疗结果提供了一个有希望的选择.

相关概念视频

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...